Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0"	"Cell type enriched"	"Detected in many"	10	"Late spermatids: 3052.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	84	"Leukemia: 30.1;lymphoma: 34.7;Myeloma: 16.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 51: Late spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 32.0;retina: 45.8;testis: 20.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 222.1;Basal prostatic cells: 74.8;Cone photoreceptor cells: 163.7;Excitatory neurons: 69.6;Inhibitory neurons: 108.2;Rod photoreceptor cells: 142.9"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Low cancer specificity"	"Detected in some"			"Adipose visceral - T-cells, Breast - T-cells, Heart muscle - Cardiomyocytes, Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Testis - Early spermatids, Thyroid - T-cells"									HPA040470	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 63: Astrocytes - Nervous system maintenance"			"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"
ADAM8	"CD156, CD156A, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262420-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.6;lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 106.5;Langerhans cells: 165.1;NK-cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 21.2"	"Group enriched"	"Detected in many"	5	"basophil: 107.4;eosinophil: 259.0;neutrophil: 139.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 259.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 58.7"	"Adipose visceral - Neutrophils, Breast - T-cells, Heart muscle - Neutrophils, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 75: Myeloid cells - Innate immune response"			"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512941-36724549	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 60.5;Kupffer cells: 93.5;Macrophages: 75.0;Microglial cells: 227.1;monocytes: 89.5;NK-cells: 101.0;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 298.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"colorectal cancer: 4.1;Leukemia: 6.1;lymphoma: 3.4"	"Breast - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Stomach - Macrophages, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA021666, HPA026716"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Vesicles	"Endoplasmic reticulum"	"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"
APOBEC3D	"APOBEC3DE, APOBEC3E, ARP6"	ENSG00000243811	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3D"	Q96AK3	22	39021113-39033277	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.7;Microglial cells: 2.7;NK-cells: 2.9;Plasma cells: 4.6;Sertoli cells: 2.8;T-cells: 4.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Myeloma: 11.6"	"Breast - T-cells, Liver - T-cells, Thyroid - T-cells"									HPA055116	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"			"HPA055116: AB_2682701"	"prognostic favorable (2.51e-5)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.69e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (4.76e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (3.01e-4)"
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.9;Cytotrophoblasts: 6.8;Hofbauer cells: 4.2;NK-cells: 8.3;Sertoli cells: 5.5;T-cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.2;MAIT T-cell: 9.4;memory CD4 T-cell: 12.1;memory CD8 T-cell: 19.4;naive CD8 T-cell: 8.9;NK-cell: 19.7;T-reg: 11.9"	"Group enriched"	"Detected in many"	13	"NK-cells: 19.7;T-cells: 23.2"	"Group enriched"	"Detected in some"	5	"Leukemia: 6.6;lymphoma: 7.8;Myeloma: 5.3"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Lung - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Sertoli cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 1: T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (8.43e-7)"
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.3;Early spermatids: 119.5;Hofbauer cells: 50.7;NK-cells: 176.8;Spermatocytes: 78.1;T-cells: 102.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Leukemia: 35.3;lymphoma: 19.9;Myeloma: 14.7"	"Breast - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415208	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 72.3;Plasma cells: 33.1;T-cells: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells, Heart muscle - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA012565	Approved		Uncertain	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 7: NK-cells - Immune response regulation"	Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (4.81e-4)"
BTN3A2	BTN3.2	ENSG00000186470	"Butyrophilin subfamily 3 member A2"	P78410	6	26365159-26378320	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.3"	"Cell type enhanced"	"Detected in many"		"NK-cells: 184.1;T-cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells"									CAB019392	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB019392: "	"unprognostic (3.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.89e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-3)"
BTN3A3	"BTF3, BTN3.3"	ENSG00000111801	"Butyrophilin subfamily 3 member A3"	O00478	6	26440472-26453415	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 30.7;Plasma cells: 23.7;T-cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells"									"HPA007904, HPA011871"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 7: NK-cells - Immune response regulation"			"HPA007904: AB_1078307, HPA011871: AB_1845496"	"unprognostic (1.18e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.13e-3)"	"unprognostic (8.08e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.54e-3)"
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295628-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 69.1;Kupffer cells: 21.8;Langerhans cells: 19.5;monocytes: 54.7;NK-cells: 37.9;T-cells: 15.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	9	"Leukemia: 24.4"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - Cardiomyocytes, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906142-3043867	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Immunity		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 34.0;dendritic cells: 36.4;Microglial cells: 48.3;NK-cells: 52.7;T-cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.4"	"Cancer enhanced"	"Detected in many"		"lymphoma: 69.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052984	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.10e-4)"
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.7;lung: 35.8;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3223.0;Langerhans cells: 892.6;Macrophages: 1326.6;monocytes: 700.9;NK-cells: 552.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 23.6"	"Group enriched"	"Detected in many"	4	"B-cells: 10.4;granulocytes: 10.8;T-cells: 23.6"	"Cancer enriched"	"Detected in some"	7	"Myeloma: 179.7"	"Breast - T-cells, Liver - NK-cells (Liver), Thyroid - T-cells"														"Secreted to blood"	NA	NA	138000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 51: Myeloma - Humoral immune response"	"Cluster 69: Macrophages - Innate immune response"				"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.90e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.23e-2)"
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103827-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1411.1;Macrophages: 1080.9;monocytes: 1343.3;NK-cells: 4730.9;T-cells: 2177.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 414.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 135.0;T-cells: 414.7"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 53.2"	"Adipose subcutaneous - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Testis - Late spermatids, Thyroid - T-cells"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;lymphoid tissue: 20.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 829.2;Langerhans cells: 428.4;Macrophages: 455.3;monocytes: 188.7;NK-cells: 649.0;T-cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 122.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 122.0"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 10.5"	"Breast - T-cells, Thyroid - T-cells"														"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 11: Non-specific - Transcription"				"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951644-32956349	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.0;urinary bladder: 5.4"	"Cell type enriched"	"Detected in some"	4	"T-cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 60.9"	"Lineage enriched"	"Detected in many"	41	"T-cells: 60.9"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 24.0"	"Adipose subcutaneous - T-cells, Breast - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031613	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	4	"NK-cells: 202.8;T-cells: 464.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	88	"Leukemia: 10.9;lymphoma: 16.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 30.8;placenta: 14.8"	"Group enriched"	"Detected in some"	10	"Hofbauer cells: 31.4;T-cells: 58.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 101.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 101.9"	"Cancer enriched"	"Detected in some"	14	"Myeloma: 98.7"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid - T-cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA070003	Enhanced					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 51: Myeloma - Humoral immune response"	"Cluster 1: T-cells - Immune response"			"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1698.7;dendritic cells: 539.1;granulocytes: 459.9;Hofbauer cells: 485.4;Langerhans cells: 414.6;monocytes: 749.0;NK-cells: 383.4;T-cells: 394.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Leukemia: 70.9;lymphoma: 194.7"	"Breast - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	6	"NK-cells: 218.3;T-cells: 639.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Cancer enriched"	"Detected in some"	7	"Leukemia: 123.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 16.3;Distal tubular cells: 21.8;granulocytes: 39.9;Ionocytes: 13.8;Salivary duct cells: 18.1;Schwann cells: 37.5"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.5"	"Breast - T-cells, Kidney - Intercalated cells, Liver - NK-cells (Liver), Testis - Early spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: TT & NCI-H1385 - Synaptic signal transduction"	"Cluster 46: Granulocytes - Mast cell degranulation"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872643	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 14.2;Macrophages: 10.9;monocytes: 13.5;NK-cells: 55.4;T-cells: 50.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 54.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 54.0;T-cells: 33.3"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells"	"Region enriched"	"Detected in some"	44	"cerebellum: 102.6"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.7"							NA	NA		6800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021118-76023497	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 49.4;Exocrine glandular cells: 20.8;Glandular and luminal cells: 24.0;Hofbauer cells: 22.7;Langerhans cells: 29.3;Macrophages: 40.2;monocytes: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 21.5;intermediate monocyte: 52.4;non-classical monocyte: 36.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 52.4"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 12.0;lymphoma: 25.2"	"Breast - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	253000		"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 33: Macrophages - Degranulation"				"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118149	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1175.1;lymphoid tissue: 549.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 1675.4;dendritic cells: 2180.0;monocytes: 1143.3;NK-cells: 1206.4;Schwann cells: 1000.5;T-cells: 1642.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 184.9;lymphoma: 220.2;Myeloma: 144.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 105.6;lymphoid tissue: 114.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.4;Langerhans cells: 667.1;monocytes: 789.8;NK-cells: 358.3;Plasma cells: 335.3;T-cells: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"lymphoma: 81.8;Myeloma: 106.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA007191	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: Lymphoma - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.4;dendritic cells: 15.9;Hofbauer cells: 17.1;monocytes: 22.3;NK-cells: 33.8;T-cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"Leukemia: 20.9;lymphoma: 27.0;Myeloma: 8.4"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143169-96145440	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 355.4;Langerhans cells: 1081.0;monocytes: 470.1;NK-cells: 831.5;T-cells: 786.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 55.0"	"Immune cell enhanced"	"Detected in all"		"gdT-cell: 199.3"	"Group enriched"	"Detected in all"	10	"NK-cells: 148.1;T-cells: 199.3"	"Cancer enriched"	"Detected in many"	4	"lymphoma: 70.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 1: T-cells - Immune response"	"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant transcription factor 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;skin 1: 15.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 30.4;Exocrine glandular cells: 18.4;Proximal enterocytes: 23.0;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9;T-reg: 16.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3"	"Low cancer specificity"	"Detected in many"			"Breast - T-cells, Thyroid - T-cells"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 11: Lymphoma - Adaptive immune response"	"Cluster 28: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113537	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 98.9;Extravillous trophoblasts: 85.5;Late spermatids: 411.5;Proximal tubular cells: 101.1;Suprabasal keratinocytes: 103.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 22.8"	"Breast - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 51: Late spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"
GPR18		ENSG00000125245	"G protein-coupled receptor 18"	Q14330	13	99254732-99261744	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.7;lymphoid tissue: 38.9;testis: 13.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 88.7;Late spermatids: 242.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 65.3;NK-cells: 52.9;T-cells: 41.9"	"Group enriched"	"Detected in some"	13	"Leukemia: 6.8;lymphoma: 21.4"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013873	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 36: Spermatids - Spermatogenesis"			"HPA013873: AB_1849285"	"unprognostic (3.87e-6)"	"unprognostic (1.31e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.31e-6)"	"unprognostic (2.89e-1)"	"unprognostic (7.55e-4)"	"unprognostic (4.27e-5)"	"unprognostic (3.45e-3)"	"unprognostic (2.31e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.20e-6)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.92e-3)"
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024256-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 99.6"	"Group enriched"	"Detected in many"	6	"NK-cells: 135.1;T-cells: 259.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 741.6;NK-cell: 505.5"	"Group enriched"	"Detected in many"	199	"NK-cells: 505.5;T-cells: 741.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063181, HPA065895"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"HPA063181: AB_2684955, HPA065895: "	"prognostic favorable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"
H1-3	"H1.3, H1d, H1F3, H1s-2, HIST1H1D"	ENSG00000124575	"H1.3 linker histone, cluster member"	P16402	6	26234212-26234987	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.1;brain: 24.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 45.7;Erythroid cells: 80.3;NK-cells: 70.0;Plasma cells: 122.3;T-cells: 90.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 24.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA055907	Supported					NA	NA		4000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: Non-specific - Nucleosome assembly"	"Cluster 40: Plasma cells - Humoral immune response"			"HPA055907: AB_2682966"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.61e-8)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-2)"
H2AC7	"H2A.3, H2A/g, H2AFG, HIST1H2AD"	ENSG00000196866	"H2A clustered histone 7"	P20671	6	26198784-26199293	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.7;Gastric mucus-secreting cells: 1.8;Paneth cells: 2.5;Plasma cells: 2.2;Spermatogonia: 2.0;T-cells: 2.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.9"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: Non-specific - Nucleosome assembly"	"Cluster 40: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"
H2BC7	"H2B/g, H2BFG, HIST1H2BF"	ENSG00000277224	"H2B clustered histone 7"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 7.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 12.5;Plasma cells: 35.8;Prostatic glandular cells: 22.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: Non-specific - Nucleosome assembly"	"Cluster 40: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"
H3C4	"H3/b, H3FB, HIST1H3D"	ENSG00000197409	"H3 clustered histone 4"	P68431	6	26196784-26197286	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.2;brain: 15.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.0;Gastric mucus-secreting cells: 8.9;Plasma cells: 16.1;Squamous epithelial cells: 5.5;T-cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells"									HPA042570	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: Non-specific - Nucleosome assembly"	"Cluster 40: Plasma cells - Humoral immune response"			"HPA042570: AB_2678056"	"unprognostic (8.64e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (2.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"
H4C5	"H4/j, H4FJ, HIST1H4E"	ENSG00000276966	"H4 clustered histone 5"	P62805	6	26204552-26206038	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 69.4"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 16.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 69.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells"									HPA042201	Supported					NA	NA		25000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: Non-specific - Nucleosome assembly"	"Cluster 40: Plasma cells - Humoral immune response"			"HPA042201: AB_2677898"	"unprognostic (8.62e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.08e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.28e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"
HEATR9	"C17orf66, FLJ32830"	ENSG00000270379	"HEAT repeat containing 9"	A2RTY3	17	35854946-35868891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 10.1"	"Group enriched"	"Detected in some"	23	"Early spermatids: 79.3;Late spermatids: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA023129	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 36: Spermatids - Spermatogenesis"			"HPA023129: AB_1845599"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.44e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.61e-10)"	"unprognostic (6.78e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.61e-3)"
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.5;lymphoid tissue: 7.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 82.4;T-cells: 208.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	NA	NA	1470		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 10.7;monocytes: 34.1;NK-cells: 55.5;Plasma cells: 12.1;T-cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"Leukemia: 9.3;lymphoma: 22.4;Myeloma: 27.4"	"Breast - T-cells, Lung - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"HPA074414: AB_2686687"	"unprognostic (7.70e-3)"	"prognostic favorable (3.41e-4)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.93e-2)"
IL23R	IL-23R	ENSG00000162594	"Interleukin 23 receptor"	Q5VWK5	1	67138907-67259979	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.6;testis: 1.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 11.5;Late spermatids: 7.5;T-cells: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"MAIT T-cell: 21.7"	"Lineage enriched"	"Detected in single"	29	"T-cells: 21.7"	"Group enriched"	"Detected in some"	8	"Leukemia: 3.1;lymphoma: 2.8;Myeloma: 1.2;Sarcoma: 1.0"	"Adipose visceral - T-cells, Breast - T-cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056427	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 7: NK-cells - Immune response regulation"			"HPA056427: AB_2683129"	"unprognostic (4.01e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.41e-3)"
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 18.3;testis: 26.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 461.0"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 35.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 103.4"	"Group enriched"	"Detected in many"	6	"monocytes: 36.8;T-cells: 103.4"	"Cancer enhanced"	"Detected in many"		"lymphoma: 33.8"	"Breast - T-cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 50: L-1236 & L-428 - Unknown function"	"Cluster 23: Langerhans cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615983	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2;lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in many"	10	"dendritic cells: 1073.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	12	"plasmacytoid DC: 596.9"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 596.9"	"Low cancer specificity"	"Detected in many"			"Breast - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017694, HPA052757"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 48: Plasmacytoid dendritic cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: AB_2681937"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"
ITGA4	CD49D	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181538940	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 47.1;lymphoid tissue: 74.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 98.7;Erythroid cells: 160.8;Kupffer cells: 123.6;Macrophages: 101.9;monocytes: 215.7;NK-cells: 274.1;Plasma cells: 115.9;T-cells: 154.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 110.4;Myeloma: 78.8"	"Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 12.9"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191323-53207282	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 38.2;NK-cells: 96.8;Plasma cells: 104.7;Schwann cells: 33.3;T-cells: 57.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	16	"Myeloma: 981.4"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042277			Approved	"Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 25.3;Hofbauer cells: 17.5;monocytes: 21.5;NK-cells: 22.2;Plasma cells: 19.8;T-cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 11.5;lymphoma: 24.7;Myeloma: 19.8"	"Breast - T-cells, Prostate - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 2: T-cells - T-cell receptor"	"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 275.0;Hofbauer cells: 105.6;Kupffer cells: 135.5;Langerhans cells: 331.4;Macrophages: 148.9;monocytes: 205.6;T-cells: 85.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Group enriched"	"Detected in some"	10	"Leukemia: 6.4;lymphoma: 15.9"	"Adipose subcutaneous - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Macrophages, Thyroid - T-cells"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 33: Macrophages - Degranulation"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.8;Bipolar cells: 26.6;Cone photoreceptor cells: 34.5;Late spermatids: 84.4;monocytes: 22.6;NK-cells: 21.9;Rod photoreceptor cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Group enriched"	"Detected in many"	8	"Leukemia: 30.4;lymphoma: 35.2;Myeloma: 74.8"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 51: Late spermatids - Spermatogenesis"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	5	"NK-cells: 17.4;Oligodendrocyte precursor cells: 34.7;T-cells: 9.4"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cancer enhanced"	"Detected in some"		"lymphoma: 6.8;thyroid cancer: 5.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"	
KLRC4	NKG2-F	ENSG00000183542	"Killer cell lectin like receptor C4"	O43908	12	10407382-10409757	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.4"	"Group enriched"	"Detected in some"	7	"NK-cells: 25.4;T-cells: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"gdT-cell: 8.2;memory CD8 T-cell: 5.9;naive CD8 T-cell: 6.7;NK-cell: 4.7"	"Group enriched"	"Detected in many"	59	"NK-cells: 4.7;T-cells: 8.2"	"Cancer enhanced"	"Detected in some"		"lymphoma: 8.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Pancreas - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Early spermatids, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (3.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.60e-1)"		"unprognostic (7.00e-2)"	"unprognostic (1.55e-4)"		"unprognostic (1.89e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.51e-3)"
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.6;ovary: 18.6"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 39.2;Peritubular cells: 66.1;T-cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 12.6;MAIT T-cell: 10.0;memory CD8 T-cell: 11.0"	"Lineage enriched"	"Detected in single"	49	"T-cells: 12.6"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 12.3"	"Breast - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Intracellular and membrane"	NA	NA		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: Lymphoma - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Intellectual disability, Leukodystrophy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.6;Erythroid cells: 71.2;Extravillous trophoblasts: 66.2;Late spermatids: 82.9;NK-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells, Colon - Mitotic cells (Colon), Skin - Mitotic cells (Skin), Stomach - Mitotic cells (Stomach), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757, CAB079954"	Supported		Supported	"Nuclear membrane"		NA	NA		2100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 43: Non-specific - Cell proliferation"	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"
LRFN1	"KIAA1484, SALM2"	ENSG00000128011	"Leucine rich repeat and fibronectin type III domain containing 1"	Q9P244	19	39306566-39320863	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Horizontal cells: 14.1;NK-cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 35: Bipolar cells - Visual perception"				"unprognostic (4.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.36e-4)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.75e-2)"	"unprognostic (4.25e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.45e-3)"	"unprognostic (1.08e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.89e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.78e-1)"
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.1;lymphoid tissue: 56.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 43.5;dendritic cells: 52.8;Langerhans cells: 30.6;monocytes: 22.5;Plasma cells: 34.7;Rod photoreceptor cells: 65.2;T-cells: 39.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"Leukemia: 16.9;lymphoma: 52.8;Myeloma: 29.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 44: Photoreceptor cells - Visual perception"	"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.5;brain: 41.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 70.6;Hofbauer cells: 50.4;NK-cells: 303.1;T-cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 76.8"	"Group enriched"	"Detected in many"	57	"NK-cells: 76.8;T-cells: 46.2"	"Cancer enhanced"	"Detected in many"		"Leukemia: 52.8"	"Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 673.3"	"Cell type enriched"	"Detected in some"	55	"B-cells: 982.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 350.5"	"Breast - T-cells, Lung - B-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7"	"Group enriched"	"Detected in some"	37	"B-cells: 140.9;dendritic cells: 228.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	61	"Leukemia: 40.6;lymphoma: 90.8"	"Adipose visceral - T-cells, Breast - T-cells, Lung - B-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"
NKG7	"GIG1, GMP-17"	ENSG00000105374	"Natural killer cell granule protein 7"	Q16617	19	51371606-51372701	"Predicted intracellular proteins, Predicted membrane proteins"	"Cytolysis, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 602.6;lymphoid tissue: 154.6"	"Cell type enriched"	"Detected in many"	5	"NK-cells: 6101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 6827.0;MAIT T-cell: 2871.2;memory CD8 T-cell: 4295.0;naive CD8 T-cell: 3114.2;NK-cell: 4796.8"	"Group enriched"	"Detected in all"	44	"NK-cells: 4796.8;T-cells: 6827.0"	"Group enriched"	"Detected in some"	26	"Leukemia: 62.9;lymphoma: 64.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071454			Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	Vesicles		"HPA071454: AB_2686399"	"unprognostic (1.56e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (7.42e-6)"	"unprognostic (1.27e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.89e-3)"	"unprognostic (3.39e-1)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (7.62e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.44e-3)"
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.5;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 10.6;Erythroid cells: 10.5;NK-cells: 32.2;T-cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Leukemia: 10.5;lymphoma: 13.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"
OR2I1P	"HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P"	ENSG00000237988	"Olfactory receptor family 2 subfamily I member 1 pseudogene"		6	29550407-29557721	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.9;Rod photoreceptor cells: 2.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - T-cells, Pancreas - Ductal cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 18: Non-specific - Mixed function"				"unprognostic (7.45e-3)"	"unprognostic (1.69e-2)"	"unprognostic (6.00e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.34e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (4.00e-6)"	"unprognostic (8.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-2)"
PATL2	Pat1a	ENSG00000229474	"PAT1 homolog 2"	C9JE40	15	44665732-44711316	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.7;lymphoid tissue: 17.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 29.8;Cardiomyocytes: 22.4;NK-cells: 39.6;T-cells: 27.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 21.6"	"Cancer enhanced"	"Detected in some"		"lymphoma: 6.4;Myeloma: 12.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 50: L-1236 & L-428 - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (3.30e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-4)"
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 365.9;esophagus: 92.0;intestine: 236.0;lymphoid tissue: 155.1;stomach 1: 117.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1487.4;Distal enterocytes: 1382.1;Extravillous trophoblasts: 711.2;monocytes: 425.9;NK-cells: 741.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - T-cells, Breast - T-cells, Colon - Colon enterocytes, Prostate - T-cells, Stomach - Gastric mucous cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 50: Enterocytes - Absorption"	Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.7;Kupffer cells: 40.2;Macrophages: 42.0;Microglial cells: 38.3;monocytes: 57.5;NK-cells: 23.1;Schwann cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	5	"Leukemia: 35.3"	"Breast - T-cells, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 33: Macrophages - Degranulation"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;retina: 14.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 164.8;Exocrine glandular cells: 70.7;Hepatocytes: 178.6;Proximal tubular cells: 226.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;NK-cells: 1.1;T-cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"							HPA055947	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 60: Proximal tubular cells - Absorption"	Nucleoplasm		"HPA055947: AB_2682981"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.99e-4)"
PMAIP1	"APR, NOXA"	ENSG00000141682	"Phorbol-12-myristate-13-acetate-induced protein 1"	Q13794	18	59899996-59904305	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 606.9;Basal squamous epithelial cells: 471.7;Endometrial ciliated cells: 483.2;Glandular and luminal cells: 557.5;Squamous epithelial cells: 446.1;Suprabasal keratinocytes: 601.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 169.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 169.8"	"Low cancer specificity"	"Detected in many"			"Breast - T-cells, Kidney - Endothelial cells, Skin - Keratinocyte (other), Testis - Spermatogonia"									HPA051063	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 14: Endometrium - Transcription regulation"	Vesicles		"HPA051063: AB_2681330"	"unprognostic (1.35e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.12e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.09e-1)"
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells, Heart muscle - Endothelial cells, Skeletal muscle - Endothelial cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 19: Macrophages - Innate immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 43.8;granulocytes: 71.9;NK-cells: 133.5;T-cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Group enriched"	"Detected in some"	41	"Leukemia: 72.3;lymphoma: 27.8;Myeloma: 22.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Testis - Sertoli cells, Thyroid - T-cells"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"
RAB37		ENSG00000172794	"RAB37, member RAS oncogene family"	Q96AX2	17	74670578-74747335	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;brain: 20.8;lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 23.5;Excitatory neurons: 32.7;granulocytes: 47.2;Horizontal cells: 28.8;Inhibitory neurons: 28.9;monocytes: 21.5;NK-cells: 55.1;T-cells: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 269.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.7"	"Cancer enhanced"	"Detected in many"		"Leukemia: 44.3;Myeloma: 20.3"	"Breast - T-cells, Testis - Early spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 4: Platelets - Platelet activation"				"unprognostic (2.10e-2)"	"unprognostic (7.04e-4)"	"unprognostic (5.95e-2)"	"unprognostic (9.80e-4)"	"unprognostic (3.49e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.62e-3)"	"unprognostic (9.47e-3)"	"unprognostic (3.05e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (8.80e-6)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (4.01e-2)"
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225270-37244448	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 411.9;lymphoid tissue: 387.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 322.2;granulocytes: 501.6;monocytes: 297.7;NK-cells: 519.2;Plasma cells: 299.5;T-cells: 411.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 357.2;lymphoma: 336.6"	"Breast - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					NA	Yes		3300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB022946: , HPA047820: AB_2680167"	"prognostic favorable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.5;intestine: 19.8;lung: 10.6;lymphoid tissue: 39.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 39.5;dendritic cells: 22.6;granulocytes: 24.5;monocytes: 31.6;NK-cells: 90.9;T-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"Leukemia: 24.3;lymphoma: 22.6;Myeloma: 28.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"	"Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;lymphoid tissue: 45.7;retina: 29.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.2;Muller glia cells: 74.0;NK-cells: 109.5;T-cells: 89.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 10.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 10.3"	"Cancer enhanced"	"Detected in many"		"lymphoma: 19.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skin - Keratinocyte (other), Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 50: L-1236 & L-428 - Unknown function"	"Cluster 1: T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA039389: AB_2732481"	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696499-88706408	"Enzymes, Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.2;lymphoid tissue: 101.6"	"Cell type enhanced"	"Detected in all"		"monocytes: 80.6;NK-cells: 154.4;T-cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"
RUBCNL	"C13orf18, FLJ21562, KIAA0226L, PACER"	ENSG00000102445	"Rubicon like autophagy enhancer"	Q9H714	13	46334681-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 132.8;dendritic cells: 91.9;Late spermatids: 126.6;Microglial cells: 62.0;Schwann cells: 56.3"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2"	"Group enriched"	"Detected in many"	15	"B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0"	"Cancer enriched"	"Detected in many"	5	"lymphoma: 143.4"	"Breast - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favorable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"
RUFY4	"FLJ46536, ZFYVE31"	ENSG00000188282	"RUN and FYVE domain containing 4"	Q6ZNE9	2	218034960-218090581	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;lymphoid tissue: 2.2"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 9.3;Langerhans cells: 5.4;Oligodendrocyte precursor cells: 12.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037980	Uncertain					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 17: Granulosa cells - Transcription regulation"			"HPA037980: AB_10672501"	"unprognostic (1.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.39e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.41e-14)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.43e-5)"
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 253.7;T-cells: 72.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - Alpha cells, Prostate - T-cells, Testis - Early spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 7: NK-cells - Immune response regulation"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"
SAMD9L	"C7orf6, FLJ39885, KIAA2005"	ENSG00000177409	"Sterile alpha motif domain containing 9 like"	Q8IVG5	7	93130056-93148385	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.3"	"Cell type enhanced"	"Detected in many"		"NK-cells: 61.5;Paneth cells: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Myeloma: 27.3"	"Breast - T-cells"	"Low region specificity"	"Detected in all"							"HPA019461, HPA019465, HPA019488"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 19: Macrophages - Innate immune response"	Cytosol		"HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557"	"unprognostic (6.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.22e-1)"
SAP25	FLJ00248	ENSG00000205307	"Sin3A associated protein 25"	Q8TEE9	7	100572228-100573900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.8;Microglial cells: 9.1;Oligodendrocyte precursor cells: 2.4;Oligodendrocytes: 7.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Leukemia: 21.4"	"Breast - T-cells"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062610			Approved	"Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 63: Astrocytes - Nervous system maintenance"	"Nuclear bodies"		"HPA062610: AB_2684806"	"unprognostic (1.70e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.09e-5)"	"unprognostic (6.89e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.96e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.52e-6)"	"unprognostic (7.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-3)"
SEPTIN1	"DIFF6, PNUTL3, SEPT1"	ENSG00000180096	"Septin 1"	Q8WYJ6	16	30378133-30395991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 16.7;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 98.3;NK-cells: 87.5;T-cells: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	58	"Leukemia: 27.5;lymphoma: 32.6;Myeloma: 19.8"	"Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339, HPA073635"	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	"Actin filaments"		"HPA041566: AB_10794671, HPA060339: , HPA073635: "	"unprognostic (3.65e-3)"	"prognostic favorable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favorable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"
SP140L		ENSG00000185404	"SP140 nuclear body protein like"	Q9H930	2	230327184-230403732	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 57.9;NK-cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells, Thyroid - T-cells"									HPA055864	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA055864: AB_2682949"	"unprognostic (1.44e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (5.09e-10)"	"unprognostic (9.15e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-3)"
STAT4		ENSG00000138378	"Signal transducer and activator of transcription 4"	Q14765	2	191029576-191151596	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;testis: 29.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 65.7;Early spermatids: 320.6;Excitatory neurons: 84.7;Late spermatids: 77.7;NK-cells: 226.8;T-cells: 125.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 76.6;T-cells: 121.2"	"Cancer enhanced"	"Detected in many"		"Myeloma: 7.4"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001860, CAB013108"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 1: T-cells - Immune response"			"CAB013108: , HPA001860: AB_1080104"	"unprognostic (3.90e-5)"	"unprognostic (1.30e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (2.65e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 235.3;dendritic cells: 89.0;Langerhans cells: 70.5;Macrophages: 85.3;monocytes: 75.4;NK-cells: 128.5;Plasma cells: 202.8;T-cells: 211.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Leukemia: 9.8;lymphoma: 16.6;Myeloma: 7.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Lung - T-cells, Prostate - T-cells, Skeletal muscle - Fibroblasts, Testis - Peritubular cells, Thyroid - T-cells"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.4;dendritic cells: 65.2;Hofbauer cells: 31.6;Langerhans cells: 53.3;Macrophages: 37.4;monocytes: 44.9;Plasma cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	169	"Leukemia: 44.5;lymphoma: 16.3;Myeloma: 21.3"	"Breast - T-cells, Liver - Kupffer cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 34: Plasma cells - Humoral immune response"	Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Horizontal cells: 3.2;Skeletal myocytes: 3.0;Spermatocytes: 3.2;Spermatogonia: 3.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Breast - T-cells, Kidney - Podocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 9: Neurons - Nervous system development"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6460786-6466175	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;pituitary gland: 29.9;skin 1: 25.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 28.7;Excitatory neurons: 37.0;T-cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"MAIT T-cell: 5.6;memory CD4 T-cell: 4.4;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.4;T-reg: 7.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Breast - T-cells, Skeletal muscle - Fibroblasts"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.4;hippocampal formation: 2.0"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 56: Neurons - Neuronal signaling"	"Cluster 1: T-cells - Immune response"	"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"
TNIP3	"ABIN-3, FLJ21162, LIND"	ENSG00000050730	"TNFAIP3 interacting protein 3"	Q96KP6	4	121131408-121227466	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.4;urinary bladder: 4.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.3;Early spermatids: 11.4;Late spermatids: 46.0;monocytes: 11.2;T-cells: 16.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 6.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Breast - T-cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043063	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 50: L-1236 & L-428 - Unknown function"	"Cluster 6: Late spermatids - Spermatogenesis"			"HPA043063: AB_10793989"	"unprognostic (2.89e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.23e-3)"	"unprognostic (8.75e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.84e-7)"	"unprognostic (3.35e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.78e-2)"
TRAC		ENSG00000277734	"T cell receptor alpha constant"		14	22547506-22552156	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	7	"lymphoid tissue: 787.9"	"Cell type enriched"	"Detected in many"	6	"T-cells: 504.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"MAIT T-cell: 2123.1;memory CD4 T-cell: 2939.7;memory CD8 T-cell: 2508.6;naive CD4 T-cell: 2671.8;naive CD8 T-cell: 2388.0;T-reg: 4379.2"	"Lineage enriched"	"Detected in all"	41	"T-cells: 4379.2"	"Group enriched"	"Detected in many"	6	"Leukemia: 132.2;lymphoma: 81.4"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skeletal muscle - Fibroblasts, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"prognostic favorable (3.21e-4)"	"prognostic favorable (4.87e-6)"	"unprognostic (9.92e-3)"	"prognostic favorable (4.15e-6)"	"unprognostic (3.71e-2)"	"prognostic favorable (5.25e-5)"	"unprognostic (2.83e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.51e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (2.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.75e-2)"
TRAV1-2		ENSG00000256553	"T cell receptor alpha variable 1-2"	A0A0B4J238	14	21642889-21643578	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 19.3"	"Cell type enriched"	"Detected in single"	5	"T-cells: 4.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"MAIT T-cell: 2027.8"	"Lineage enriched"	"Detected in many"	507	"T-cells: 2027.8"	"Cancer enriched"	"Detected in some"	21	"Bone cancer: 126.0"	"Breast - T-cells, Lung - T-cells"															NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: Bone cancer - Transcription"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.19e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-3)"		"unprognostic (5.87e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.56e-2)"	"unprognostic (8.90e-2)"	"unprognostic (6.50e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.30e-2)"
TRAV12-2		ENSG00000211789	"T cell receptor alpha variable 12-2"	A0A075B6T6	14	21887857-21888502	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 22.4"	"Cell type enriched"	"Detected in some"	4	"T-cells: 9.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"memory CD4 T-cell: 101.9;memory CD8 T-cell: 87.7;naive CD4 T-cell: 90.3;naive CD8 T-cell: 65.2;T-reg: 143.3"	"Lineage enriched"	"Detected in many"	77	"T-cells: 143.3"	"Cancer enriched"	"Detected in single"	328	"lymphoma: 32.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.22e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.23e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.01e-2)"
TRAV12-3	"TCRAV12S3, TCRAV2S2, TRAV123"	ENSG00000211794	"T cell receptor alpha variable 12-3"	A0A0B4J271	14	21965451-21966061	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 60.3"	"Cell type enriched"	"Detected in some"	4	"T-cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 186.5;T-reg: 256.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 256.6"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.62e-4)"	"unprognostic (7.68e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.55e-4)"	"unprognostic (9.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.52e-5)"	"unprognostic (3.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.68e-2)"
TRAV13-2		ENSG00000211791	"T cell receptor alpha variable 13-2"	A0A0B4J235	14	21918188-21918756	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in some"		"NK-cells: 2.0;Prostatic glandular cells: 1.8;T-cells: 6.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	38	"MAIT T-cell: 32.9;memory CD4 T-cell: 94.0;memory CD8 T-cell: 57.3;naive CD4 T-cell: 101.8;naive CD8 T-cell: 114.1;T-reg: 114.8"	"Lineage enriched"	"Detected in many"	53	"T-cells: 114.8"	"Group enriched"	"Detected in some"	4	"lymphoma: 2.8;Rhabdoid: 1.0"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.15e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.58e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.66e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-2)"
TRAV16	"TCRAV16S1, TCRAV9S1"	ENSG00000211796	"T cell receptor alpha variable 16"	A0A0A6YYK6	14	21990496-21990938	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 39.8"	"Cell type enriched"	"Detected in some"	5	"T-cells: 5.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 48.0;T-reg: 58.0"	"Lineage enriched"	"Detected in single"	164	"T-cells: 58.0"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 8.3"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells"					"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.93e-2)"	"unprognostic (1.06e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.67e-3)"		"unprognostic (1.01e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.94e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.07e-3)"
TRAV2		ENSG00000211776	"T cell receptor alpha variable 2"	A0A0B4J234	14	21712321-21712843	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	21	"lymphoid tissue: 56.3"	"Cell type enriched"	"Detected in single"	29	"T-cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 40.9"	"Lineage enriched"	"Detected in single"	124	"T-cells: 40.9"	"Cancer enhanced"	"Detected in some"		"Leukemia: 12.8;lymphoma: 3.2"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.38e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.93e-2)"		"unprognostic (1.86e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.93e-5)"	"unprognostic (1.92e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"
TRAV21		ENSG00000211801	"T cell receptor alpha variable 21"	A0A0B4J279	14	22052514-22053056	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 63.2"	"Cell type enriched"	"Detected in some"	6	"T-cells: 24.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 220.5;memory CD8 T-cell: 233.5;naive CD4 T-cell: 198.6;naive CD8 T-cell: 204.8;T-reg: 391.9"	"Lineage enriched"	"Detected in many"	76	"T-cells: 391.9"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"					"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.53e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.69e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.20e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"
TRAV23DV6	"TCRAV17S1, TRAV23/DV6"	ENSG00000211803	"T cell receptor alpha variable 23/delta variable 6"	A0A075B6W5	14	22086407-22086961	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 26.3"	"Cell type enriched"	"Detected in single"	22	"T-cells: 3.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 79.3;naive CD4 T-cell: 85.6;T-reg: 65.6"	"Lineage enriched"	"Detected in many"	56	"T-cells: 85.6"	"Cancer enriched"	"Detected in single"	358	"Leukemia: 35.7"	"Breast - T-cells, Lung - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (7.79e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.69e-1)"		"unprognostic (2.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.47e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.33e-1)"
TRAV25	"TCRAV25S1, TCRAV32S1"	ENSG00000211806	"T cell receptor alpha variable 25"	A0A0B4J276	14	22112347-22113031	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 15.2"	"Cell type enriched"	"Detected in single"	5	"T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	63	"memory CD4 T-cell: 33.5;memory CD8 T-cell: 20.9;naive CD4 T-cell: 32.6;naive CD8 T-cell: 22.5;T-reg: 49.4"	"Lineage enriched"	"Detected in single"	404	"T-cells: 49.4"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 1.0"	"Breast - T-cells, Lung - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (9.50e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.22e-2)"			"unprognostic (2.89e-5)"		"unprognostic (6.65e-3)"	"unprognostic (7.53e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.52e-3)"	"unprognostic (9.55e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.74e-1)"
TRAV3		ENSG00000211777	"T cell receptor alpha variable 3"	A0A0B4J244	14	21723713-21724321	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 10.1"	"Cell type enriched"	"Detected in some"	5	"T-cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 48.8;memory CD8 T-cell: 33.6;naive CD4 T-cell: 51.2;naive CD8 T-cell: 47.8;T-reg: 112.7"	"Lineage enriched"	"Detected in single"	144	"T-cells: 112.7"	"Group enriched"	"Detected in some"	26	"Bone cancer: 15.8;Leukemia: 11.0"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.32e-3)"	"unprognostic (4.61e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.25e-3)"	"unprognostic (7.75e-2)"	"unprognostic (8.35e-4)"	"unprognostic (8.65e-3)"	"unprognostic (4.31e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.24e-3)"	"unprognostic (5.27e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.91e-4)"	"unprognostic (1.67e-1)"	"unprognostic (6.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"
TRAV4	"TCRAV20S1, TCRAV4S1"	ENSG00000211778	"T cell receptor alpha variable 4"	A0A0B4J268	14	21736152-21736982	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 37.9"	"Cell type enriched"	"Detected in single"	9	"T-cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	70	"MAIT T-cell: 66.1;memory CD4 T-cell: 81.9;memory CD8 T-cell: 124.0;naive CD4 T-cell: 77.1;naive CD8 T-cell: 81.0;T-reg: 167.9"	"Lineage enriched"	"Detected in many"	118	"T-cells: 167.9"	"Group enriched"	"Detected in some"	54	"Bone cancer: 2.5;Leukemia: 8.1"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.13e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.18e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (6.49e-2)"
TRAV5		ENSG00000211779	"T cell receptor alpha variable 5"	A0A0B4J249	14	21749178-21749705	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 12.9"	"Cell type enriched"	"Detected in some"	4	"T-cells: 5.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	52	"MAIT T-cell: 24.7;memory CD4 T-cell: 49.5;memory CD8 T-cell: 77.3;naive CD4 T-cell: 39.9;naive CD8 T-cell: 74.0;T-reg: 81.4"	"Lineage enriched"	"Detected in many"	73	"T-cells: 81.4"	"Group enriched"	"Detected in some"	9	"Leukemia: 34.9;lymphoma: 12.8"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.04e-3)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-2)"		"unprognostic (6.26e-5)"	"unprognostic (3.58e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.38e-6)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.70e-2)"
TRAV6	TCRAV5S1	ENSG00000211780	"T cell receptor alpha variable 6"	A0A075B6T7	14	21768489-21769080	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 11.2"	"Group enriched"	"Detected in some"	13	"dendritic cells: 2.1;T-cells: 4.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	70	"MAIT T-cell: 17.1;memory CD4 T-cell: 33.7;memory CD8 T-cell: 19.0;naive CD4 T-cell: 26.3;naive CD8 T-cell: 16.2;T-reg: 59.6"	"Lineage enriched"	"Detected in single"	146	"T-cells: 59.6"	"Group enriched"	"Detected in some"	26	"Bone cancer: 6.8;Leukemia: 1.8"	"Breast - T-cells"					"Not detected"	"Not detected"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: Bone cancer - Transcription"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.78e-1)"		"unprognostic (3.49e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.87e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.24e-2)"
TRAV8-1		ENSG00000211782	"T cell receptor alpha variable 8-1"	A0A0A6YYK1	14	21797287-21797886	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 11.8"	"Cell type enriched"	"Detected in single"	13	"T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	43	"MAIT T-cell: 14.2;memory CD4 T-cell: 39.5;memory CD8 T-cell: 20.6;naive CD4 T-cell: 37.6;naive CD8 T-cell: 16.3;T-reg: 54.4"	"Lineage enriched"	"Detected in single"	77	"T-cells: 54.4"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.0"	"Adipose visceral - T-cells, Breast - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (8.53e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.34e-2)"		"unprognostic (4.86e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.19e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (2.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.86e-1)"	"unprognostic (5.72e-2)"
TRAV9-2		ENSG00000211793	"T cell receptor alpha variable 9-2"	A0A087WT02	14	21941128-21941657	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 27.8"	"Cell type enriched"	"Detected in single"	8	"T-cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 178.3;naive CD4 T-cell: 172.2;T-reg: 350.8"	"Lineage enriched"	"Detected in many"	78	"T-cells: 350.8"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"		"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.02e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-4)"		"unprognostic (1.14e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.98e-4)"	"unprognostic (9.53e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.00e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.56e-2)"
TRBJ1-1	"TCRBJ1S1, TRBJ11"	ENSG00000282320	"T cell receptor beta joining 1-1"	A0A0J9YXA8	7	142786880-142786927	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 83.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 1111.5"	"Lineage enriched"	"Detected in all"	18	"T-cells: 1111.5"	"Cancer enriched"	"Detected in some"	7	"Leukemia: 9.5"	"Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"																				
TRBJ2-5	"TCRBJ2S5, TRBJ25"	ENSG00000211769	"T cell receptor beta joining 2-5"		7	142797119-142797166	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"bone marrow: 2.7;intestine: 4.5;lymphoid tissue: 10.9;stomach 1: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 1102.2"	"Lineage enriched"	"Detected in all"	14	"T-cells: 1102.2"	"Cancer enhanced"	"Detected in some"		"Leukemia: 25.7;lymphoma: 10.6"	"Breast - T-cells"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"																				
TRBV15	"TCRBV15S1, TCRBV24S1A3T"	ENSG00000276819	"T cell receptor beta variable 15"		7	142592928-142593473	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	67	"lymphoid tissue: 46.9"	"Cell type enriched"	"Detected in single"	13	"T-cells: 2.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	48	"MAIT T-cell: 21.9;memory CD4 T-cell: 14.6;memory CD8 T-cell: 21.1;naive CD4 T-cell: 18.8;naive CD8 T-cell: 12.3;T-reg: 27.8"	"Lineage enriched"	"Detected in single"	158	"T-cells: 27.8"	"Cancer enriched"	"Detected in single"	133	"Leukemia: 20.7"	"Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.07e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.39e-3)"		"unprognostic (2.09e-4)"	"unprognostic (1.08e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (7.77e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.34e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.55e-2)"
TRBV18	TCRBV18S1	ENSG00000276557	"T cell receptor beta variable 18"	A0A087X0M5	7	142615716-142616415	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	17	"lymphoid tissue: 27.5"	"Cell type enriched"	"Detected in single"	8	"T-cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 102.0"	"Lineage enriched"	"Detected in single"	316	"T-cells: 102.0"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.53e-3)"	"unprognostic (7.74e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.08e-4)"	"unprognostic (3.11e-1)"	"unprognostic (6.76e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.81e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.28e-6)"	"unprognostic (3.80e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.47e-2)"
TRBV23-1	"TCRBV19S1P, TCRBV23S1, TRBV231"	ENSG00000211749	"T cell receptor beta variable 23-1 (non-functional)"		7	142645961-142646467	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.02e-5)"	"unprognostic (7.32e-4)"				"unprognostic (1.71e-4)"		"unprognostic (1.34e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.64e-2)"		"unprognostic (1.17e-6)"	"unprognostic (1.14e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.37e-1)"	
TRBV24-1	"TCRBV15S1, TCRBV24S1, TRBV241"	ENSG00000211750	"T cell receptor beta variable 24-1"	A0A075B6N3	7	142656701-142657213	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;lymphoid tissue: 6.7"	"Cell type enriched"	"Detected in single"	4	"T-cells: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.7"	"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 26.6"	"Lineage enriched"	"Detected in single"	129	"T-cells: 26.6"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Prostate - T-cells, Skeletal muscle - Skeletal myocytes, Thyroid - T-cells"															NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.42e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-7)"	"unprognostic (2.36e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.39e-2)"
TRBV3-1	"TCRBV3S1, TCRBV9S1A1T, TRBV31"	ENSG00000237702	"T cell receptor beta variable 3-1"	A0A576	7	142308542-142309048	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 51.1"	"Group enriched"	"Detected in some"	15	"Plasma cells: 7.0;T-cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 52.4;memory CD8 T-cell: 45.9;naive CD4 T-cell: 71.6;naive CD8 T-cell: 117.4;T-reg: 99.6"	"Lineage enriched"	"Detected in many"	32	"T-cells: 117.4"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (7.98e-5)"	"unprognostic (2.38e-3)"	"unprognostic (5.19e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.26e-2)"
TRBV4-1	"BV07S1J2.7, TCRBV4S1, TCRBV7S1A1N2T, TRBV41"	ENSG00000211710	"T cell receptor beta variable 4-1"	A0A577	7	142313184-142313666	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 115.0"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 4.2;T-cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 176.7"	"Lineage enriched"	"Detected in many"	89	"T-cells: 176.7"	"Cancer enriched"	"Detected in single"	71	"lymphoma: 11.0"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.58e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.71e-5)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.99e-2)"
TRBV4-2	"TCRBV4S2, TCRBV7S3A2T, TRBV42"	ENSG00000211745	"T cell receptor beta variable 4-2"	A0A539	7	142345421-142345985	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 21.0"	"Cell type enriched"	"Detected in some"	7	"T-cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 100.2"	"Lineage enriched"	"Detected in single"	293	"T-cells: 100.2"	"Cancer enriched"	"Detected in single"	250	"Leukemia: 29.6"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.89e-3)"	"unprognostic (4.65e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.05e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.82e-4)"	"unprognostic (5.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-2)"
TRBV5-1	"TCRBV5S1, TCRBV5S1A1T, TRBV51"	ENSG00000211734	"T cell receptor beta variable 5-1"	A0A578	7	142320677-142321544	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 44.0"	"Cell type enriched"	"Detected in some"	11	"T-cells: 14.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 211.6;T-reg: 295.5"	"Lineage enriched"	"Detected in many"	111	"T-cells: 295.5"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Lung - T-cells, Prostate - T-cells, Testis - Late spermatids, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 7: Neuronal cell lines - Stereocilium"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.26e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.49e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.02e-5)"	"unprognostic (2.55e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.85e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.96e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.97e-2)"
TRBV5-4	"TCRBV5S4, TCRBV5S6A3N2T, TRBV54"	ENSG00000230099	"T cell receptor beta variable 5-4"	A0A0C4DH59	7	142462916-142463581	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 22.1;pancreas: 11.6"	"Group enriched"	"Detected in some"	8	"Plasma cells: 4.1;T-cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 115.7"	"Lineage enriched"	"Detected in many"	115	"T-cells: 115.7"	"Group enriched"	"Detected in some"	6	"Leukemia: 3.3;ovarian cancer: 1.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.48e-3)"	"unprognostic (6.75e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.64e-2)"
TRBV5-6	"TCRBV5S2, TCRBV5S6, TRBV56"	ENSG00000211728	"T cell receptor beta variable 5-6"	A0A599	7	142500028-142500534	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	19	"lymphoid tissue: 33.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.7;Late spermatids: 16.3;T-cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 40.2;memory CD8 T-cell: 22.9;naive CD4 T-cell: 35.9;naive CD8 T-cell: 45.2;T-reg: 66.0"	"Lineage enriched"	"Detected in many"	56	"T-cells: 66.0"	"Cancer enriched"	"Detected in single"	416	"Leukemia: 44.6"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Testis - Late spermatids, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.27e-3)"	"unprognostic (8.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.45e-4)"	"unprognostic (5.72e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.26e-7)"	"unprognostic (7.62e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.34e-1)"
TRBV6-2	"TCRBV13S2A1T, TCRBV6S2, TRBV62"	ENSG00000283063	"T cell receptor beta variable 6-2"	"A0A0J9YXY3, P0DPF7"	7	142349152-142349664	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 8.2"	"Group enriched"	"Detected in some"	7	"Erythroid cells: 1.9;T-cells: 7.5"					"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 92.1"	"Lineage enriched"	"Detected in single"	175	"T-cells: 92.1"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"																				
TRBV6-6	"TCRBV13S6A2T, TCRBV6S6, TRBV66"	ENSG00000211724	"T cell receptor beta variable 6-6"	A0A0A6YYG2	7	142469537-142470013	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 14.7"	"Cell type enriched"	"Detected in single"	35	"T-cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 81.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 81.4"	"Cancer enriched"	"Detected in single"	39	"Leukemia: 8.8"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.69e-4)"	"unprognostic (3.82e-4)"	"unprognostic (3.66e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.93e-5)"	"unprognostic (4.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.01e-2)"
TRBV7-2	"TCRBV6S5A1N1, TCRBV7S2, TRBV72"	ENSG00000282939	"T cell receptor beta variable 7-2"	A0A1B0GXF2	7	142352819-142353358	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	11	"epididymis: 35.6;lymphoid tissue: 85.5"	"Cell type enriched"	"Detected in some"	5	"T-cells: 30.1"					"Region enriched"	"Detected in single"	5	"hypothalamus: 1.1"	"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 397.4;T-reg: 570.3"	"Lineage enriched"	"Detected in many"	79	"T-cells: 570.3"	"Cancer enriched"	"Detected in single"	46	"Leukemia: 13.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"																				
TRBV7-6	"TCRBV6S3A1N1T, TCRBV7S6, TRBV76"	ENSG00000211727	"T cell receptor beta variable 7-6"	A0A1B0GX31	7	142492132-142492673	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 35.3"	"Group enriched"	"Detected in some"	18	"Gastric mucus-secreting cells: 6.0;Macrophages: 2.4;T-cells: 7.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	22	"memory CD4 T-cell: 54.7;memory CD8 T-cell: 42.7;naive CD4 T-cell: 62.0;naive CD8 T-cell: 37.2;T-reg: 86.1"	"Lineage enriched"	"Detected in many"	52	"T-cells: 86.1"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 2: DU4475 - Unknown function"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (4.74e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.25e-5)"	"unprognostic (4.86e-3)"	"unprognostic (4.06e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.83e-5)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.86e-5)"	"unprognostic (1.83e-1)"	"unprognostic (7.27e-2)"	"unprognostic (5.90e-2)"	"unprognostic (6.22e-3)"
TRGV2	"TCRGV2, VIS2"	ENSG00000233306	"T cell receptor gamma variable 2"	A0A075B6R0	7	38362864-38363518	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 6.6"	"Cell type enriched"	"Detected in some"	6	"T-cells: 18.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 147.8"	"Lineage enriched"	"Detected in many"	22	"T-cells: 147.8"	"Group enriched"	"Detected in some"	13	"Leukemia: 3.9;lymphoma: 1.8;Myeloma: 3.2"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.51e-3)"	"unprognostic (8.88e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.21e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-3)"
TTC16	FLJ32780	ENSG00000167094	"Tetratricopeptide repeat domain 16"	Q8NEE8	9	127716079-127731590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"fallopian tube: 6.9;testis: 16.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 91.0;Late spermatids: 259.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 6: Late spermatids - Spermatogenesis"				"unprognostic (3.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-4)"	"unprognostic (4.08e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.87e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.54e-3)"
TTC24		ENSG00000187862	"Tetratricopeptide repeat domain 24"	A2A3L6	1	156579723-156587719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 21.2"	"Cell type enriched"	"Detected in some"	9	"dendritic cells: 53.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.7;plasmacytoid DC: 12.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.4;NK-cells: 3.7"	"Group enriched"	"Detected in some"	16	"Leukemia: 7.1;lymphoma: 4.5"	"Breast - T-cells, Lung - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029799			Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 48: Plasmacytoid dendritic cells - Unknown function"	Nucleoplasm		"HPA029799: AB_10601684"	"unprognostic (2.43e-3)"	"unprognostic (5.61e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-6)"	"unprognostic (6.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.87e-9)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.76e-4)"
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enriched"	"Detected in some"	5	"T-cells: 21.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	57	"Leukemia: 8.9;lymphoma: 2.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559732	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 151.3"	"Group enriched"	"Detected in many"	9	"Ductal cells: 421.1;Exocrine glandular cells: 613.6;Pancreatic endocrine cells: 168.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bile duct cancer: 21.6;thyroid cancer: 43.3"	"Breast - T-cells, Pancreas - Ductal cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 74: Pancreatic cells - Mixed function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540768-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.4"	"Group enriched"	"Detected in many"	14	"NK-cells: 529.3;T-cells: 240.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"NK-cell: 423.5"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 423.5"	"Cancer enriched"	"Detected in some"	7	"Sarcoma: 7.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"									HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: TE 441.T - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"			"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"
ZBTB32	"FAXF, FAZF, Rog, TZFP, ZNF538"	ENSG00000011590	"Zinc finger and BTB domain containing 32"	Q9Y2Y4	19	35704558-35717038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 19.3;Early spermatids: 42.9;Late spermatids: 69.7;Plasma cells: 26.0;Spermatocytes: 91.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.4"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 10.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.5"	"Group enriched"	"Detected in some"	5	"lymphoma: 11.1;Myeloma: 3.9"	"Breast - T-cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076730	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 42: Spermatocytes & Spermatids - Spermatogenesis"			"HPA076730: AB_2732320"	"unprognostic (2.11e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-5)"	"unprognostic (2.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-8)"	"unprognostic (2.44e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.94e-3)"
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 81.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 346.9;Late spermatids: 550.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 172.4;memory CD8 T-cell: 113.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 172.4"	"Cancer enriched"	"Detected in single"	5	"Leukemia: 2.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Pancreas - T-cells, Testis - Late spermatids, Thyroid - T-cells"					"Not detected"	"Not detected"			HPA023865	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 24: Spermatids - Unknown function"			"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (3.45e-5)"
ZNF80	pT17	ENSG00000174255	"Zinc finger protein 80"	P51504	3	114234631-114237578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	5	"NK-cells: 3.6;Pancreatic endocrine cells: 3.4;T-cells: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Cancer enriched"	"Detected in single"	6	"lymphoma: 1.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells"									HPA065484	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"HPA065484: AB_2685496"	"unprognostic (6.27e-3)"	"unprognostic (3.00e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-5)"	"unprognostic (5.36e-1)"	"unprognostic (6.52e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.69e-12)"	"unprognostic (1.85e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-2)"